Cyrocin is a synthetic broad spectrum antimicrobial agent for oral and IV administration.
CYROCIN 250mg Tablets: Each film coated tablet contains: Ciprofloxacin (as hydrochloride) USP ............... 250mg. ® CYROCIN 500mg Tablets: Each film coated tablet contains: Ciprofloxacin (as hydrochloride) USP ............... 500mg. ® CYROCIN Dry Powder for Suspension 125mg: Each 5ml of reconstituted suspension contains: Ciprofloxacin (as hydrochloride) USP ............125mg. ® CYROCIN Dry Powder for Suspension 250mg: Each 5ml of reconstituted suspension contains: Ciprofloxacin (as hydrochloride) USP ............250mg. ® CYROCIN I.V. 200mg/100ml Infusion: 100ml contains: Ciprofloxacin (as lactate) USP ............ 200mg.
(adults) Ciprofloxacin is indicated in Urinary Tract Infections, Acute Uncomplicated Cystitis in females, Chronic Bacterial Prostatitis, Lower Respiratory Tract Infections, Acute Sinusitis, Skin and Skin Structure Infections, Complicated Intra-Abdominal Infections (used in combination with metronidazole), Infectious Diarrhea, Uncomplicated cervical and urethral gonorrhea.
DOSAGE & ADMINISTRATION:
The duration of treatment depends upon the severity of infection. The usual duration is 7 to 14 days; however, for severe and complicated infections more prolonged therapy may be required.
Ciprofloxacin is contraindicated in persons with a history of hypersensitivity to Ciprofloxacin, any member of the quinolone class of antimicrobial agents, or any of the product components. Concomitant administration with tizanidine is contraindcated.
Cyrocin 250mg & 500mg are available in blister packing of 10s. Cyrocin IV 200 mg per 100 ml. solution is available in the packing of 1’s.
PREGNANCY & LACTATION:
Should be used during pregnancy only if the potential benefit justifies the potential risk of the fetus. The drug should be used only after taking into account the benefits offered and the potential risks involved.